Eli Lilly Stock Drops After Fake Twitter Blue Account Announces Free Insulin
A prankster uses Twitter's new paid verification system to post a fake announcement about free insulin, causing Eli Lilly's stock to fall sharply. The incident highlights the growing chaos surrounding Elon Musk's rollout of the Twitter Blue subscription service.
Eli Lilly issues a public apology after a fake Twitter account falsely announces that the company provides free insulin. The impostor account easily gains a blue verification checkmark by paying eight dollars a month for Twitter Blue, a new subscription service introduced under Elon Musk's ownership. This paid feature replaces the old system where Twitter manually verified accounts to confirm their legitimacy.
The misleading tweet causes Eli Lilly's stock price to drop sharply as investors react to the false information. Other major corporations and public figures, including Lockheed Martin, Nintendo, and LeBron James, face similar impersonation attacks from pranksters exploiting the new verification policy. The wave of fake accounts becomes so disruptive that Twitter temporarily suspends the availability of the Twitter Blue service on Friday.
This situation demonstrates the major risks of stripping away the traditional meaning of the platform's blue checkmark. Pharmaceutical companies like Eli Lilly already face heavy public scrutiny over high drug prices, making them especially vulnerable to this type of misinformation. The company clarifies the situation by directing users to its official account, but the financial damage from the prank is already done.